Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus
Go back to Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus| (NASDAQ: APYX) | Delayed: 4.69 +0.04 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.65 | 52 Week High | $ | |||
| Open | $4.66 | 52 Week Low | $ | |||
| Day High | $4.99 | P/E | N/A | |||
| Day Low | $4.63 | EPS | $ | |||
| Volume | 119,603 | |||||

